[Diseases of the thyroid gland].
D003630:Daunorubicin / Q000627:therapeutic use; D006042:Goiter / Q000453:epidemiology; D006111:Graves Disease / Q000188:drug therapy / Q000453:epidemiology; D006402:Hematologic Diseases / Q000145:classification; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000532:radiotherapy; D007456:Iodine Isotopes / Q000627:therapeutic use; D009230:Myxedema / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012877:Skin Manifestations; D013972:Thyrotropin / Q000494:pharmacology; D013974:Thyroxine / Q000627:therapeutic use
D007456:Iodine Isotopes; D012110:Reserpine; D013972:Thyrotropin; D013974:Thyroxine; D011241:Prednisone; D003630:Daunorubicin
Erkrankungen der Schilddrüse.